Opportunities and Challenges in the Management of Advanced STS

Program Goals

Sarcoma: The Scope of the Clinical Problem

Epidemiology of STS

Sarcomas: Biological Groups, Etiology, and Risk Factors

Diagnosis and Pathology of Sarcomas

Management of Sarcomas: Therapeutic Progress and Ongoing Clinical Needs

Doxorubicin vs Intensified Doxorubicin Plus Ifosfamide for Advanced STS: Phase 3

Doxorubicin vs Intensified Doxorubicin Plus Ifosfamide: Post-protocol Treatment

Pazopanib for Metastatic STS: Phase 3 PALETTE Trial

Subanalysis of Phase 2 and 3 Data of Long-term Responders on Pazopanib

HRQoL Reported in the PALETTE Study

Gemcitabine Plus Docetaxel vs Doxorubicin as First-line Therapy in Metastatic STS: Phase 3 GeDDis Trial

GeDDis Trial: Subgroup Analysis

Individualizing Therapy for Patients With Advanced STS

Abbreviations